Cargando…

Evolution of Early-Phase Anticancer Drug Investigations in China

This study examines phase 1 anticancer drug clinical trials performed in China from 2017 to 2021.

Detalles Bibliográficos
Autores principales:	Wang, Shuhang, Yu, Yue, Jiang, Yale, Zhang, Huishan, Ma, Peiwen, Liu, Gang, Li, Ning
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	American Medical Association 2022
Materias:	Research Letter
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9459900/ https://www.ncbi.nlm.nih.gov/pubmed/36074496 http://dx.doi.org/10.1001/jamaoncol.2022.3856

Ejemplares similares

Seven-year exclusivity and beyond for drugs of rare diseases in China
por: Jiang, Yale, et al.
Publicado: (2023)

Outcome measures of phase III anticancer drug trials in China
por: Guo, Lanwei, et al.
Publicado: (2023)

Evolution of drug regulations and regulatory innovation for anticancer drugs in China
por: Liu, Yang, et al.
Publicado: (2022)

The current status and future of ADC therapy for small cell Lung Cancer: a promising approach
por: Zhou, Jiawei, et al.
Publicado: (2023)

The global landscape of neoadjuvant and adjuvant anti-PD-1/PD-L1 clinical trials
por: Wu, Dawei, et al.
Publicado: (2022)

Clinical Investigations of CAR-T Cell Therapy for Solid Tumors
por: Chen, Kun, et al.
Publicado: (2022)

Targeting rare tumors: new focus for clinical research in China
por: Wang, Shuhang, et al.
Publicado: (2022)

Phase I clinical trials of anticancer drugs in healthy volunteers: Need for critical consideration
por: Gupta, Pooja, et al.
Publicado: (2012)

Identification of Tumor Antigens and Immune Subtypes of Malignant Mesothelioma for mRNA Vaccine Development
por: Wang, Shuhang, et al.
Publicado: (2022)

Pharmacokinetic Imaging with Radiolabeled Molecularly Targeted Anticancer Drugs
por: Bauer, Martin, et al.
Publicado: (2020)

Access to anticancer medicines in public hospitals of Northwestern China
por: Ma, Yue, et al.
Publicado: (2023)

Anticancer drug R&D landscape in China
por: Zhao, Shen, et al.
Publicado: (2020)

Availability and Affordability of Oncology Drugs in 2012-2021 in China and the United States
por: Huang, Huiyao, et al.
Publicado: (2022)

CAR-macrophage: An extensive immune enhancer to fight cancer
por: Wang, Shuhang, et al.
Publicado: (2022)

Successful Confinement of a Familial Cluster of COVID-19 in Qingdao, China, in the Early Phase of Pandemic
por: Jia, Jing, et al.
Publicado: (2020)

Ocular toxicity of investigational anti-cancer drugs in early phase clinical trials
por: Takamizawa, Shigemasa, et al.
Publicado: (2022)

Characterization of an Extensively Drug-Resistant Salmonella enterica Serovar Indiana Strain Harboring Chromosomal bla(NDM-9) in China
por: Wang, Jing, et al.
Publicado: (2022)

KRAS Mutation in Rare Tumors: A Landscape Analysis of 3453 Chinese Patients
por: Wang, Shuhang, et al.
Publicado: (2022)

Evolution of p53 pathway-related genes provides insights into anticancer mechanisms of natural longevity in cetaceans
por: Liu, Xing, et al.
Publicado: (2023)

Association between germ-line HLA and immune-related adverse events
por: Jiang, Ning, et al.
Publicado: (2022)

Anticancer bispecific antibody R&D advances: a study focusing on research trend worldwide and in China
por: Zhang, Zhonghan, et al.
Publicado: (2021)

Unfair older patients restriction in cancer drug trials in mainland China and corresponding solution
por: Huang, Huiyao, et al.
Publicado: (2023)

Reliability and validity of the Caregiver Reported Early Development Instruments (CREDI) in impoverished regions of China
por: Li, Ying, et al.
Publicado: (2020)

Multiscale Approach to Investigate Self-Assembly of Telodendrimer Based Nanocarriers for Anticancer Drug Delivery
por: Jiang, Wenjuan, et al.
Publicado: (2014)

Combination Early-Phase Trials of Anticancer Agents in Children and Adolescents
por: Moreno, Lucas, et al.
Publicado: (2023)

Anticancer medicines in China: Trends in daily therapy cost and relative procurement volume and spending
por: Huang, Tao, et al.
Publicado: (2021)

Microfluidic cell squeeze-based vaccine comes into clinical investigation
por: Wang, Shuhang, et al.
Publicado: (2023)

The necessity of detailed epidemiological investigation in the early stage of an outbreak: lessons from a six‐case cluster of COVID‐19 in Guangzhou, China
por: Gu, Yuzhou, et al.
Publicado: (2020)

HCV 6a was expanding and became the predominant subtype among blood donors between 2004 and 2019 in Guangdong, China
por: Du, Rongsong, et al.
Publicado: (2022)

A multivalent biparatopic EGFR-targeting nanobody drug conjugate displays potent anticancer activity in solid tumor models
por: Fan, Jiansheng, et al.
Publicado: (2021)

Evolution of telemedicine in China during COVID-19 pandemic: from 2020 to 2022
por: Chen, Rukun, et al.
Publicado: (2022)

Prickly waterlily and rigid hornwort genomes shed light on early angiosperm evolution
por: Yang, Yongzhi, et al.
Publicado: (2020)

Prevalence and Drug Resistance of Nontuberculous Mycobacteria, Northern China, 2008–2011
por: Wang, Xiaobo, et al.
Publicado: (2014)

Early stage release control of an anticancer drug by drug-polymer miscibility in a hydrophobic fiber-based drug delivery system
por: Yuan, Yue, et al.
Publicado: (2018)

Comparison of Demand for Drugs Used for COVID-19 Treatment and Other Drugs During the Early Phase of the COVID-19 Pandemic in Italy
por: Ammassari, Adriana, et al.
Publicado: (2021)

The Prevalence of the Potential Drug-Drug Interactions Involving Anticancer Drugs in China: A Retrospective Study
por: WANG, Weilan, et al.
Publicado: (2019)

Retrovolution: HIV–Driven Evolution of Cellular Genes and Improvement of Anticancer Drug Activation
por: Rossolillo, Paola, et al.
Publicado: (2012)

The Anticancer Drugs
por: Wilkinson, P.
Publicado: (1980)

Anticancer drug discovery by targeting cullin neddylation
por: Yu, Qing, et al.
Publicado: (2020)

Does early supplementation of vitamin A show good efficacy on the prevention of bronchopulmonary dysplasia?
por: Wu, Jiangfeng, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_3jk71ujps8mdv392q5unlvlu77